Literature DB >> 20540630

Lipoprotein-A and carotid intima media thickness as cardiovascular risk factors in patients of chronic kidney disease.

Hari Krishan Aggarwal1, Deepak Jain, Mohit Lathar, R K Yadav, Amrish Sawhney.   

Abstract

Patients in all stages of chronic kidney disease (CKD) are considered in the "high-risk group" for development of cardiovascular disease (CVD). The study was undertaken in 60 adult patients of chronic renal failure. The patients were divided into three groups: Group I had subjects with CKD (stages 1 and 2); Group II had subjects with CKD (stages 3 and 4) on conservative therapy for 3 months; and Group III had subjects with CKD (stage 5) on regular hemodialysis for at least 3-4 weeks. Carotid sonography was done in all patients at the time of inclusion in the study. The patients in all the groups were then followed for 6 months and the relevant investigations were carried out, initially at the time of presentation, and then at third- and sixth-month interval. The patients were monitored for various renal parameters along with serum lipoprotein-A [Lp (A)]. The value of carotid intima media thickness (CA-IMT) was increased in group II and III as compared to group I. The calcification of carotids was higher in patients of group III. The maximum number of patients having plaques and stenosis in the carotids were seen in group III (50%), followed by group II (20%). Patients in group III had 5-10 times higher levels of Lp (A) as compared to patients in group I. The comparison of Lp (A) levels between group I and group II was also highly statistically significant.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20540630     DOI: 10.3109/0886022X.2010.486097

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

Review 1.  Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.

Authors:  Gates Colbert; Nishank Jain; James A de Lemos; S Susan Hedayati
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-17       Impact factor: 8.237

Review 2.  Lipoprotein (a): impact by ethnicity and environmental and medical conditions.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Lars Berglund
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

3.  Carotid atherosclerotic disease predicts cardiovascular events in hemodialysis patients: a prospective study.

Authors:  Sílvia Collado; Elisabeth Coll; Carlos Nicolau; Mercedes Pons; Josep M Cruzado; Julio Pascual; Aleix Cases
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

4.  Serum lipoprotein (a) and atherosclerotic changes in hemodialysis patients.

Authors:  Mahmoud Rafieian-Kopaei; Hamid Nasri
Journal:  J Renal Inj Prev       Date:  2013-06-01

5.  Relationship between lipoprotein (a) and micro/macro complications in type 2 diabetes mellitus: a forgotten target.

Authors:  Rocio Toro; Eduardo Segura; Jesús Millan Nuñez-Cortes; Juan Carlos Pedro-Botet; Maribel Quezada-Feijoo; Alipio Mangas
Journal:  J Geriatr Cardiol       Date:  2015-03       Impact factor: 3.327

Review 6.  The role of lipoprotein (a) in chronic kidney disease.

Authors:  Jemma C Hopewell; Richard Haynes; Colin Baigent
Journal:  J Lipid Res       Date:  2018-01-29       Impact factor: 5.922

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.